SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-16-004199
Filing Date
2016-08-15
Accepted
2016-08-15 12:50:35
Documents
3
Period of Report
2016-08-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v446934_8k.htm 8-K 17210
2 EXHIBIT 99.1 v446934_ex99-1.htm EX-99.1 14033
3 GRAPHIC image_001.jpg GRAPHIC 1839
  Complete submission text file 0001279569-16-004199.txt   34954
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

IRS No.: 981226819 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37426 | Film No.: 161831338
SIC: 2834 Pharmaceutical Preparations